Sponsor Pipeline

Gruppo Oncologico Italia Meridionale Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07381764 ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus… Metastatic Colorectal Cancer (CRC) Not Yet Recruiting
Disease Areas
Get alerts when Gruppo Oncologico Italia Meridionale's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free